National Comprehensive Cancer Network

|
|
|
|
For Patients

NCCN Research & Business Resources

Learn more about clinical trials at this NCCN Member Institution.

Profile

The Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine is an international leader in cancer treatment, research, prevention, education, and community outreach. It is the only cancer center in Missouri and within a 240-mile radius of St. Louis to hold the Comprehensive Cancer Center designation from the National Cancer Institute (NCI). Parent institutions Barnes-Jewish Hospital and Washington University School of Medicine also are nationally recognized, with U.S. News & World Report magazine consistently ranking both among the best in the country.

Siteman offers the expertise of more than 350 Washington University research scientists and physicians who provide care for nearly 8,000 newly diagnosed cancer patients each year. A full range of advanced diagnostic and treatment services are available in a state-of-the-art outpatient facility for patients with all types of cancer. Patients have access to support services throughout their care; Siteman's Barnard Health and Cancer Information Center served more than 15,000 individuals in 2007 through its education and support programs.

Scientists and physicians affiliated with Siteman hold more than $130 million in cancer research and related training grants. This includes federally funded translational initiatives in nanotechnology, chemoprevention, gene therapy, proteomics, imaging, genomics, and leukemia and lymphoma. More than 30 multiproject or collaborative cancer grants are held by Siteman investigators.

State-of-the-art research facilities include Washington University's world-renowned Genome Center and a Good Manufacturing Practice laboratory for the production of cellular and biological products that is one of the largest facilities of its type at a U.S. academic medical center.

Patients have access to more than 350 clinical trials, including many collaborative efforts with other leading cancer centers, enhancing Siteman's bench-to-bedside care approach. Washington University's Mallinckrodt Institute of Radiology was a founding member of the Radiation Therapy Oncology Group, and Siteman participates in a variety of other cooperative clinical research groups.

As a Comprehensive Cancer Center, Siteman is committed to community outreach, education, and screening. Last year, the cancer center sponsored more than 250 events with nearly 15,000 participants. Siteman's Program for the Elimination of Cancer Disparities strives to reduce barriers to cancer education, care, and research for underserved groups. In 2005, the program received a $1.25 million grant from the NCI in support of its work.